Closing the Gender Diagnostic Gap With a Sample-Collecting Tampon
Daye's diagnostic tampon, designed for self-collection of vaginal and cervical fluids to detect STIs and HPV, outperformed conventional swabs in a trial with 250 participants. The tampon, approved in the UK and US, is expected to increase STI and HPV screening participation. The trial's success relied on efficient patient recruitment strategies, including digital marketing and pre-consenting.
Reference News
Daye's diagnostic tampon, designed for self-collection of vaginal and cervical fluids to detect STIs and HPV, outperformed conventional swabs in a trial with 250 participants. The tampon, approved in the UK and US, is expected to increase STI and HPV screening participation. The trial's success relied on efficient patient recruitment strategies, including digital marketing and pre-consenting.